Funded Grants

PI Name PI Organization Title Grant Number Program Official Sort descending
Afshar-Kharghan, Vahid

University Of Tx Md Anderson Can Ctr
United States

Novel Biomarkers Predicting Blood Clots in Ovarian Cancer 1R01CA275762-01A1 Rachel Altshuler, Ph.D.
Lee, Richard T

Beckman Research Institute/City Of Hope
United States

A Pilot Study to Evaluate the Benefits of Phytocannabinoids for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy 1R21CA260447-01A1 Rachel Altshuler, Ph.D.
Noble, Mark D

University Of Rochester
United States

Prevention and treatment of paclitaxel-induced peripheral neuropathy 5R21CA277447-02 Rachel Altshuler, Ph.D.
Hu, Shuiying

Ohio State University
United States

Prevention of paclitaxel-induced peripheral neuropathy with nilotinib 5R01CA238946-05 Rachel Altshuler, Ph.D.
Khasabov, Sergey G

University Of Minnesota
United States

Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling 5R01CA263777-03 Rachel Altshuler, Ph.D.
Salvemini, Daniela

Saint Louis University
United States

Fingolimod and Ozanimod for the treatment and prevention of chemobrain 5R01CA261979-02 Rachel Altshuler, Ph.D.
Hu, Shuiying

Ohio State University
United States

Targeting neuronal transport to ameliorate vincristine neurotoxicity 1R01CA272254-01A1 Rachel Altshuler, Ph.D.
Xu, Xiangxi Mike

University Of Miami School Of Medicine
United States

Countering microtubule stabilization within hair follicles in ovarian cancer chemotherapy 1R01CA286527-01 Rachel Altshuler, Ph.D.
Hu, Shuiying

Ohio State University
United States

Prevention of paclitaxel-induced peripheral neuropathy with nilotinib 5R01CA238946-05 Rachel Altshuler, Ph.D.
Hu, Shuiying

Ohio State University
United States

Prevention of paclitaxel-induced peripheral neuropathy with nilotinib 5R01CA238946-05 Rachel Altshuler, Ph.D.